Schiffmann S - Search Results

1

The immunomodulatory potential of the arylmethylaminosteroid sc1o.

Blum L, Ulshöfer T, Henke M, Krieg R, Berneburg I, Geisslinger G, Becker K, Parnham MJ, Schiffmann S. Blum L, et al. Among authors: schiffmann s. J Mol Med (Berl). 2021 Feb;99(2):261-272. doi: 10.1007/s00109-020-02024-4. Epub 2020 Dec 17. J Mol Med (Berl). 2021. PMID: 33330947 Free PMC article.

2

Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment.

Janssen A, Maier TJ, Schiffmann S, Coste O, Seegel M, Geisslinger G, Grösch S. Janssen A, et al. Among authors: schiffmann s. Eur J Pharmacol. 2006 Jul 1;540(1-3):24-33. doi: 10.1016/j.ejphar.2006.04.030. Epub 2006 May 3. Eur J Pharmacol. 2006. PMID: 16730702

3

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.

Grösch S, Maier TJ, Schiffmann S, Geisslinger G. Grösch S, et al. Among authors: schiffmann s. J Natl Cancer Inst. 2006 Jun 7;98(11):736-47. doi: 10.1093/jnci/djj206. J Natl Cancer Inst. 2006. PMID: 16757698 Review.

4

p53 is important for the anti-proliferative effect of ibuprofen in colon carcinoma cells.

Janssen A, Schiffmann S, Birod K, Maier TJ, Wobst I, Geisslinger G, Grösch S. Janssen A, et al. Among authors: schiffmann s. Biochem Biophys Res Commun. 2008 Jan 25;365(4):698-703. doi: 10.1016/j.bbrc.2007.11.051. Epub 2007 Nov 26. Biochem Biophys Res Commun. 2008. PMID: 18036557

5

Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.

Ruckhäberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, Grösch S, Geisslinger G, Holtrich U, Karn T, Kaufmann M. Ruckhäberle E, et al. Among authors: schiffmann s. Breast Cancer Res Treat. 2008 Nov;112(1):41-52. doi: 10.1007/s10549-007-9836-9. Epub 2007 Dec 4. Breast Cancer Res Treat. 2008. PMID: 18058224

6

Dimethylcelecoxib inhibits prostaglandin E2 production.

Wobst I, Schiffmann S, Birod K, Maier TJ, Schmidt R, Angioni C, Geisslinger G, Grösch S. Wobst I, et al. Among authors: schiffmann s. Biochem Pharmacol. 2008 Jul 1;76(1):62-9. doi: 10.1016/j.bcp.2008.04.008. Epub 2008 Apr 24. Biochem Pharmacol. 2008. PMID: 18508034

7

The anti-proliferative potency of celecoxib is not a class effect of coxibs.

Schiffmann S, Maier TJ, Wobst I, Janssen A, Corban-Wilhelm H, Angioni C, Geisslinger G, Grösch S. Schiffmann S, et al. Biochem Pharmacol. 2008 Jul 15;76(2):179-87. doi: 10.1016/j.bcp.2008.04.017. Epub 2008 May 4. Biochem Pharmacol. 2008. PMID: 18547544

8

The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis.

Schiffmann S, Sandner J, Schmidt R, Birod K, Wobst I, Schmidt H, Angioni C, Geisslinger G, Grösch S. Schiffmann S, et al. J Lipid Res. 2009 Jan;50(1):32-40. doi: 10.1194/jlr.M800122-JLR200. Epub 2008 Aug 18. J Lipid Res. 2009. PMID: 18711209 Free article.

9

Ceramide synthases and ceramide levels are increased in breast cancer tissue.

Schiffmann S, Sandner J, Birod K, Wobst I, Angioni C, Ruckhäberle E, Kaufmann M, Ackermann H, Lötsch J, Schmidt H, Geisslinger G, Grösch S. Schiffmann S, et al. Carcinogenesis. 2009 May;30(5):745-52. doi: 10.1093/carcin/bgp061. Epub 2009 Mar 11. Carcinogenesis. 2009. PMID: 19279183

10

Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype.

Weigert A, Schiffmann S, Sekar D, Ley S, Menrad H, Werno C, Grosch S, Geisslinger G, Brüne B. Weigert A, et al. Among authors: schiffmann s. Int J Cancer. 2009 Nov 1;125(9):2114-21. doi: 10.1002/ijc.24594. Int J Cancer. 2009. PMID: 19618460 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page